Indonesia vs Laos: Average cost of drugs for extensively drug-resistant tuberculosis
Indonesia
1,138 constant 2022 US$
in 2024
Laos
1,250 constant 2022 US$
in 2024
Indonesia rank
40th
Laos rank
37th
Average cost of drugs for extensively drug-resistant tuberculosis over time
- Indonesia
- Laos
How they compare
Laos currently reports 1,250 constant 2022 US$ against 1,138 constant 2022 US$ in Indonesia, a difference of 112 constant 2022 US$.
That makes Laos's figure about 1.1 times Indonesia's.
The two have swapped places 1 time across 5 shared years of data; in 2020 it was Indonesia ahead.
Indonesia ranks 40th and Laos ranks 37th of 56 countries.
Indonesia has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher average cost of drugs for extensively drug-resistant tuberculosis, Indonesia or Laos?
- Laos, at 1,250 constant 2022 US$ against 1,138 constant 2022 US$ in Indonesia as of 2024.
- What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between Indonesia and Laos?
- 112 constant 2022 US$, with Laos ahead.
- How many years of comparable data are there for Indonesia and Laos?
- 5 years are reported by both, from 2020 to 2024.
- How do Indonesia and Laos rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
- Indonesia ranks 40th and Laos ranks 37th of 56 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.